Dwindling pools of manufacturers for some generic drugs are driving up prices, The New York Times reports. The paper focuses on the example of digoxin, a heart drug first described in the medical literature in 1785 that now sells for $1.60 a pill. Until recently the drug sold for far less, but the exit of manufacturers has led to decreased competition and rising costs. Article (sub. req.)